NO20062862L - 4-substituerte imidazoler - Google Patents

4-substituerte imidazoler

Info

Publication number: NO20062862L
Authority: NO; Norway
Prior art keywords: substituted imidazoles; psychotic; prophylaxis; therapy; compounds
Prior art date: 2003-11-19

Application number

NO20062862A

Other languages

English (en)

Norwegian (no)

Inventor

Eifion Phillips

James Empfield

Scott Throner

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-11-19

Filing date

2006-06-19

Publication date

2006-08-21

2006-06-19 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2006-08-21 Publication of NO20062862L publication Critical patent/NO20062862L/no

Links

-1 4-substituted imidazoles Chemical class 0.000 title 1
208000028017 Psychotic disease Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000006735 deficit Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Psychiatry (AREA)
Psychology (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20062862A 2003-11-19 2006-06-19 4-substituerte imidazoler NO20062862L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0303075A SE0303075D0 (sv)	2003-11-19	2003-11-19	4-substituted imidazoles
PCT/SE2004/001660 WO2005049612A1 (en)	2003-11-19	2004-11-15	4-substituted imidazoles

Publications (1)

Publication Number	Publication Date
NO20062862L true NO20062862L (no)	2006-08-21

Family

ID=29729099

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20062862A NO20062862L (no)	2003-11-19	2006-06-19	4-substituerte imidazoler

Country Status (13)

Country	Link
US (1)	US7384954B2 (pt)
EP (1)	EP1687303A1 (pt)
JP (1)	JP2007511603A (pt)
KR (1)	KR20060100426A (pt)
CN (1)	CN1882584A (pt)
AU (1)	AU2004291457A1 (pt)
BR (1)	BRPI0416629A (pt)
CA (1)	CA2546096A1 (pt)
IL (1)	IL175438A0 (pt)
NO (1)	NO20062862L (pt)
SE (1)	SE0303075D0 (pt)
WO (1)	WO2005049612A1 (pt)
ZA (1)	ZA200604018B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0303076D0 (sv) *	2003-11-19	2003-11-19	Astrazeneca Ab	5-substituted imidazoles
MX2007007024A (es) *	2004-12-16	2007-07-04	Astrazeneca Ab	Ligandos del receptor acetilcolina nicotinica.
FR2974365B1 (fr) *	2011-04-20	2017-08-25	Centre Nat De La Rech Scient (C N R S)	1,2,3-triazoles 1,4-disubstituees, leurs procedes de preparation et leurs utilisations diagnostiques et therapeutiques

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ226000A (en) *	1987-09-10	1991-06-25	Merck Sharp & Dohme	Oxadiazolyl-azabicycloheptanes and pharmaceutical compositions
EP1311505A2 (en) *	2000-08-21	2003-05-21	PHARMACIA & UPJOHN COMPANY	Quinuclidine-substituted heteroaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands )
AU2001284646A1 (en) *	2000-08-21	2002-03-04	Pharmacia And Upjohn Company	Quinuclidine-substituted heteroaryl moieties for treatment of disease
US20020086871A1 (en) *	2000-12-29	2002-07-04	O'neill Brian Thomas	Pharmaceutical composition for the treatment of CNS and other disorders
FR2832713B1 (fr) *	2001-11-23	2004-02-13	Sanofi Synthelabo	Derives de 4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique
EP1562945B1 (en)	2002-11-11	2006-11-15	Neurosearch A/S	1,4-diazabicyclo(3,2,2)nonane derivatives, preparation and therapeutical use thereof

2003
- 2003-11-19 SE SE0303075A patent/SE0303075D0/xx unknown
2004
- 2004-11-15 EP EP04800323A patent/EP1687303A1/en not_active Withdrawn
- 2004-11-15 CN CNA2004800342450A patent/CN1882584A/zh active Pending
- 2004-11-15 BR BRPI0416629-9A patent/BRPI0416629A/pt not_active IP Right Cessation
- 2004-11-15 JP JP2006541086A patent/JP2007511603A/ja active Pending
- 2004-11-15 AU AU2004291457A patent/AU2004291457A1/en not_active Abandoned
- 2004-11-15 US US10/579,609 patent/US7384954B2/en not_active Expired - Fee Related
- 2004-11-15 KR KR1020067009700A patent/KR20060100426A/ko not_active Withdrawn
- 2004-11-15 CA CA002546096A patent/CA2546096A1/en not_active Abandoned
- 2004-11-15 WO PCT/SE2004/001660 patent/WO2005049612A1/en not_active Ceased
2006
- 2006-05-04 IL IL175438A patent/IL175438A0/en unknown
- 2006-05-18 ZA ZA200604018A patent/ZA200604018B/en unknown
- 2006-06-19 NO NO20062862A patent/NO20062862L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2004291457A1 (en)	2005-06-02
BRPI0416629A (pt)	2007-01-16
US7384954B2 (en)	2008-06-10
KR20060100426A (ko)	2006-09-20
JP2007511603A (ja)	2007-05-10
IL175438A0 (en)	2006-09-05
US20070105896A1 (en)	2007-05-10
CN1882584A (zh)	2006-12-20
WO2005049612A1 (en)	2005-06-02
ZA200604018B (en)	2007-11-28
CA2546096A1 (en)	2005-06-02
EP1687303A1 (en)	2006-08-09
SE0303075D0 (sv)	2003-11-19

Legal Events

Date	Code	Title	Description
2009-06-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20080675L (no)	2008-03-13	P38-Map kinaseinhibitorer og metoder for deres anvendelse
NO20081729L (no)	2008-05-16	Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer
NO20053748L (no)	2005-10-07	Pyrrolopyridazinderivater.
NO20092412L (no)	2009-08-19	Hydantoinderivater anvendes som MMP-inhibitorer
NO20055421L (no)	2005-12-20	Kinolinderivater som fosfodiestrase-inhibitorer
NO20071504L (no)	2007-05-25	Pyrimidinderivanter.
NO20074703L (no)	2007-11-14	Antibakterielle piperidinderivater
NO20073572L (no)	2007-09-12	Nye forbindelser
NO20051165L (no)	2005-03-04	Benzotiazolderivater som har -adrenoerseptorantagonist aktivitet
NO20071593L (no)	2007-05-22	Pyrimidinderivater
NO20062335L (no)	2006-07-19	Nye diazaspiroalkaner og deres anvendelse i behandlingen av CCR8 medierte sykdommer
NO20092476L (no)	2009-09-02	Antibakterielle polycykliske ureaforbindelser
NO20062591L (no)	2006-09-20	Difenylazetidinonderivater med kolesterolabsorpsjonsinhiberende aktivitet
NO20081315L (no)	2008-05-15	Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser
NO20076648L (no)	2008-03-17	Novel thiophene derivatives
NO20060688L (no)	2006-04-07	Fusjonerte aryl- og heteroarylderivater som modulatorer av metabolisme og profylakse og behandling av lidelser relatert til dette
NO20050828L (no)	2005-04-05	lndol-3-svovelderivater
NO20084912L (no)	2009-02-03	Bisykliske derivater som CETP-inhibitorer
NO20054329L (no)	2005-11-21	Adamantanderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som innbefatter slike
NO20090628L (no)	2009-04-21	Pyridizinon derivativater
NO20091893L (no)	2009-07-09	Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav.
NO20076137L (no)	2008-01-18	Nye 2-azetidinonderivater og deres anvendelse som kolestrolabsorpsjonsinhibitorer for behandling av hyperlipidemi
NO20062583L (no)	2006-09-20	Difenylazetidinonderivater med kolesterolabsorpsjonsinhiberende aktivitet
NO20070570L (no)	2007-04-10	Forbindelser.
NO20081844L (no)	2008-05-29	Terapeutiske forbindelser